Faculty

Back to Index
Luanda Grazette, MD
Associate Professor of Clinical Medicine
Medicine
HCC 322 Health Sciences Campus Los Angeles
+1 323 442 6130

Overview

Dr. Luanda Grazette completed her undergraduate studies at the University of Alabama and went on to Harvard to earn her Medical Degree and Masters Degree in Public Health. She then completed her internship and residency at Massachusetts General Hospital in Boston followed by Fellowship training in Clinical Cardiology at Emory University. After completing her fellowship, Dr. Grazette returned to Massachusetts General Hospital for additional training in Heart Failure and Transplantation and Heart Failure Research and then remained on staff as a Physician-Scientist.

Her experience with follow-up care of transplant patients, supervision of students and fellows, and management of pre- and post-transplant patients in critical care settings and inpatient consultation makes her a tremendous asset to USC. In addition to her clinical responsibilities, Dr. Grazette engaged in active clinical and translational research investigating the basic mechanisms of cardiac toxicity, plasticty and survival. Dr Grazette has also served as a Medical Director of Global Clinical Research for Amgen where she overseeing early and late stage clinical trials. Myocardial plasticity and the potential for recovery remain the focus of her clinical and research activities.

Awards

National Institute of Health: K01 Mentored Faculty Development Award, 2000-2005

National Institute of Health: ORNG Application Instance for Person, 2000-2005

National Institute of Health: full name, 2000-2005

National Institute of Health: person in primary position, 2000-2005

National Institute of Health: last name, 2000-2005

National Institute of Health: In The News, 2000-2005

National Institute of Health: ORNG Application URL, 2000-2005

National Institute of Health: sort order, 2000-2005

National Institute of Health: http://orng.info/ontology/orng#ApplicationInstance^^ORNG Application Instance^^177-118, 2000-2005

National Institute of Health: email address, 2000-2005

National Institute of Health: start date, 2000-2005

National Institute of Health: featured_pub_4, 2000-2005

National Institute of Health: end date, 2000-2005

National Institute of Health: Associate Professor, 2000-2005

National Institute of Health: featured_pub_11, 2000-2005

National Institute of Health: award conferred by, 2000-2005

National Institute of Health: Faculty Rank, 2000-2005

National Institute of Health: links, 2000-2005

National Institute of Health: featured_pub_14, 2000-2005

National Institute of Health: featured_pub_7, 2000-2005

National Institute of Health: featured_pub_10, 2000-2005

National Institute of Health: Organization, 2000-2005

National Institute of Health: Grazette, Luanda, 2000-2005

National Institute of Health: ORNG Application Instance Data value, 2000-2005

National Institute of Health: Keck School of Medicine of USC, 2000-2005

National Institute of Health: is primary position, 2000-2005

National Institute of Health: Featured Publications, 2000-2005

National Institute of Health: featured_pub_13, 2000-2005

National Institute of Health: has faculty rank, 2000-2005

Publications

Heart Failure-Induced Brain Injury. J Am Coll Cardiol. 2017 Mar 28; 69(12):1609-1616. View in: PubMed

Pan-Cardiac Cycle Fixed Mitral Valve Opening in an LVAD Patient Presenting with Hemorrhagic Shock. Echocardiography. 2016 Apr; 33(4):644-646. View in: PubMed

Fulminant eosinophilic myocarditis following ICD implantation in a patient with undisclosed nickel allergy. Int J Cardiol. 2016 Jan 15; 203:1018-9. View in: PubMed

Point-of-Care Technologies for Precision Cardiovascular Care and Clinical Research: National Heart, Lung, and Blood Institute Working Group. JACC Basic Transl Sci. 2016 Jan-Feb; 1(1-2):73-86. View in: PubMed

Modern day management of giant cell myocarditis. Int J Cardiol. 2015 Jan 15; 178:82-4. View in: PubMed

Electrocardiographic patch devices and contemporary wireless cardiac monitoring. Front Physiol. 2015; 6:149. View in: PubMed

RANKL Inhibition With Denosumab Does Not Influence 3-Year Progression of Aortic Calcification or Incidence of Adverse Cardiovascular Events in Postmenopausal Women With Osteoporosis and High Cardiovascular Risk. J Bone Miner Res. 2014 Feb; 29(2):450-7. View in: PubMed

Treatment of ventricular tachycardia in patients with heart failure. Curr Cardiol Rep. 2011 Jun; 13(3):203-9. View in: PubMed

Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone mass. J Clin Endocrinol Metab. 2011 Apr; 96(4):972-80. View in: PubMed

Cardiotoxicity of the cancer therapeutic agent imatinib mesylate. Nat Med. 2006 Aug; 12(8):908-16. View in: PubMed

C4d deposition in cardiac allografts correlates with alloantibody. J Heart Lung Transplant. 2005 Sep; 24(9):1202-10. View in: PubMed

Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto-optical nanoparticle. Magn Reson Med. 2005 Sep; 54(3):718-24. View in: PubMed

PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury. J Clin Invest. 2005 Aug; 115(8):2128-38. View in: PubMed

Role of apoptosis in heart failure. Heart Fail Clin. 2005 Jul; 1(2):251-61. View in: PubMed

Inhibition of ErbB2 causes mitochondrial dysfunction in cardiomyocytes: implications for herceptin-induced cardiomyopathy. J Am Coll Cardiol. 2004 Dec 7; 44(11):2231-8. View in: PubMed

Cardiac-specific gene expression facilitated by an enhanced myosin light chain promoter. Mol Imaging. 2004 Apr; 3(2):69-75. View in: PubMed

Higher frequency of high-grade rejections in cardiac allograft patients after Quilty B lesions or grade 2/4 rejections. Transplantation. 2002 Jun 27; 73(12):1928-32. View in: PubMed

Differential activation of signal transduction pathways in human hearts with hypertrophy versus advanced heart failure. Circulation. 2001 Feb 6; 103(5):670-7. View in: PubMed

Powered bySC CTSI